tiprankstipranks
Trending News
More News >
RegenXBio (RGNX)
NASDAQ:RGNX
US Market

RegenXBio (RGNX) Technical Analysis

Compare
928 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
RegenXBio’s (RGNX) Moving Averages Convergence Divergence (MACD) indicator is 0.44, suggesting RegenXBio is a Sell.
RegenXBio’s (RGNX) 20-Day exponential moving average is 8.53, while RegenXBio’s (RGNX) share price is $10, making it a Buy.
RegenXBio’s (RGNX) 50-Day exponential moving average is 8.00, while RegenXBio’s (RGNX) share price is $10, making it a Buy.

RegenXBio (RGNX) Pivot Points

May 21, 2025, 04:30 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.87
8.26
9.03
9.42
10.19
10.58
11.35
Fibonacci
8.26
8.71
8.98
9.42
9.87
10.14
10.58
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

RegenXBio (RGNX) Moving Averages

May 21, 2025, 04:30 PM
Period
Simple
Exponential
MA5
9.13Buy
9.28Buy
MA10
8.37Buy
8.89Buy
MA20
8.85Buy
8.53Buy
MA50
7.71Buy
8.00Buy
MA100
7.56Buy
8.10Buy
MA200
9.04Buy
9.37Buy
RegenXBio’s (RGNX) 10-Day exponential moving average is 8.89, while RegenXBio’s (RGNX) share price is $10, making it a Buy.
RegenXBio’s (RGNX) 100-Day exponential moving average is 8.10, while RegenXBio’s (RGNX) share price is $10, making it a Buy.
RegenXBio’s (RGNX) stock price is $10 and RegenXBio’s (RGNX) 50-day simple moving average is 7.71, creating a Buy signal.
RegenXBio’s (RGNX) stock price is $10 and RegenXBio’s (RGNX) 100-day simple moving average is 7.56, creating a Buy signal.
RegenXBio’s (RGNX) stock price is $10 and RegenXBio’s (RGNX) 200-day simple moving average is 9.04, creating a Buy signal.

RegenXBio (RGNX) Technical Indicators

May 21, 2025, 04:30 PM
Name
Value
Implied Action
RSI (14)
64.71
Neutral
STOCH (9,6)
88.52
Sell
STOCHRSI (14)
72.16
Neutral
MACD (12,26)
0.44
Sell
ADX (14)
23.95
Neutral
Williams %R
-15.95
Sell
CCI (14)
97.54
Neutral
ATR (14)
0.83
-
Ultimate Oscillator
64.34
Neutral
ROC
4.06
Buy
RegenXBio’s (RGNX) Relative Strength Index (RSI) is 64.71, creating a Neutral signal.
RegenXBio’s (RGNX) Trend Strength Indicator (ADX) is 23.95, creating a Neutral signal.
RegenXBio’s (RGNX) Commodity Channel Index (CCI) is 97.54, creating a Neutral signal.
RegenXBio’s (RGNX) Price Rate of Change (ROC) is 4.06, creating a Buy signal.

FAQ

Is RGNX a Buy, Hold, or Sell?
Based on RGNX’s technical indicators, RGNX is a Buy.
    What is RGNX’s RSI (14)?
    RGNX’s RSI (14) is 64.71, which suggests RGNX is a Neutral.
      What is RGNX’s MACD?
      RGNX’s MACD is 0.44, which suggests RGNX is a Sell.
        What is RGNX’s 5-day moving average?
        RGNX’s 5-day moving average is 9.13, which suggests RGNX is a Buy.
          What is RGNX’s 20-day moving average?
          RGNX 20-day moving average is 8.85, which suggests RGNX is a Buy.
            What is RGNX’s 50-day moving average?
            RGNX’s 50-day moving average is 7.71, which suggests RGNX is a Buy.
              What is RGNX’s 200-day moving average?
              RGNX’s 200-day moving average is 9.04, which suggests RGNX is a Buy.
                What is RGNX’s Williams % R (14)?
                RGNX’s Williams % R (14) is -15.95, which suggests RGNX is a Sell.
                  What is RGNX’s CCI (14)?
                  RGNX’s CCI (14) is 97.54, which suggests RGNX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis